Journal of Neurology

, Volume 253, Issue 4, pp 488–495 | Cite as


Clinical description of 7 cases with a proposal for a new diagnostic strategy
  • S. Marangoni
  • V. Argentiero
  • B. Tavolato



Chronic involvement of the nervous system is relatively rare in sarcoidosis. We describe 7 cases that fulfil Zajicek's criteria for neurosarcoidosis (NS) and propose some modifications to such criteria.

Materials and methods

The patients were admitted for various neurological syndromes: 2 cases presented with chronic lymphocytic meningitis, 4 with spinal cord symptoms, one case was initially confused with multiple sclerosis. Serological tests, immunological screening, cerebrospinal fluid (CSF) analysis, bacteriological and viral testing were performed in all patients. Spinal and cerebral MRI, gallium scan, bronchoscopy with biopsy and bronchoalveolar–lavage fluid analysis, high–resolution computed tomography (HRCT) of the chest, biopsy of the lungs, skin, mediastinal lymph–node and meninges, were useful in diagnosing NS.

Results and discussion

Laboratory tests showed serum inflammatory abnormalities, but were negative for infectious diseases, while CSF showed inflammatory signs in all patients. MRI revealed meningeal enhancement or hypertrophic pachymeningeal lesions in 4 patients, white matter abnormalities and mass lesions in 2 patients, and a spinal mass lesion in 1 patient. Gallium scan, HRCT, bronchoscopy were positive in most cases. Patients were treated with steroid and immunosuppressive therapy, with improvement in six cases. One patient died from infectious complications.


A definite diagnosis of NS requires demonstration of non–caseating granulomas affecting nervous tissues. In most cases, histological evidence of systemic disease (probable NS) is sufficient in the presence of compatible alterations in the CNS. In our patients the bronchoalveolarlavage fluid analysis, gallium scan, and chest HRCT were important for diagnosis,while serum ACE was always normal and chest radiographs were not suggestive of sarcoidosis.

Key words

neurosarcoidosis CNS diseases inflammatory 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Agostini, et al. (1998) Cells and molecules involved in the development of sarcoid granuloma. J Clin Immunol 18:184–192CrossRefPubMedGoogle Scholar
  2. 2.
    Agbogu, et al. (1995) Therapeutic considerations in patients with refractory neurosarcoidosis. Arch Neurol 52:875–879PubMedGoogle Scholar
  3. 3.
    Chapelon–Abric, et al. (1991) Neurosarcoidoses. Ann Med Intern 142:601–608Google Scholar
  4. 4.
    Costabel U (1992) Sensitivity and specificity of BAL findings in sarcoidosis. Sarcoidosis 9(Suppl 1):211–214Google Scholar
  5. 5.
    Ferreby, et al. (2000) Manifestations cliniques et approche therapeutique de la neurosarcoidose: 40 cas. Rev Neurol (Paris) 156:965–975Google Scholar
  6. 6.
    Ferreby, et al. (2001) Long–term followup of neurosarcoidosis. Neurology 57:927–929Google Scholar
  7. 7.
    Howard Jaster J, et al. (1997) Solitary spinal cord sarcoidosis without other manifestations of systemic sarcoidosis. Clinical Imaging 21:17–22CrossRefGoogle Scholar
  8. 8.
    Hunninghake, et al. (1999) ATS/ERS/WASOG Statement on Sarcoidosis. Sarcoidosis vasculitis and diffuse lung diseases 16:149–173Google Scholar
  9. 9.
    Levivier M, et al. (1991) Sarcoidosis presenting as an isolated intramedullary tumor. Neurosurgery 29:271–276CrossRefPubMedGoogle Scholar
  10. 10.
    Lower, et al. (1997) Diagnosis and management of neurological sarcoidosis. Arch Intern Med 155:395–420Google Scholar
  11. 11.
    Kelly, et al. (1988) MR demonstration of spinal cord sarcoidosis: report of a case. AJNR 9:197–199PubMedGoogle Scholar
  12. 12.
    Manà J, et al. (1994) Clinical factors predicting persistence of activity in sarcoidosis: a multivariate analysis of 193 cases. Respiration 61:219–225PubMedCrossRefGoogle Scholar
  13. 13.
    Mayock, et al. (1963) Manifestations of sarcoidosis – analysis of 145 patients, with a review of nine series selected from the literature. Am J Med 35:67–89CrossRefPubMedGoogle Scholar
  14. 14.
    Moller DR (1999) Cells and cytokines involved in the pathogenesis of sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 16:24–31PubMedGoogle Scholar
  15. 15.
    Nowak, et al. (2001) Neurosarcoidosis: a review of its intracranial manifestation. J Neurol 248:363–372CrossRefPubMedGoogle Scholar
  16. 16.
    Paramothayan, et al. (2002) Corticosteroid therapy in pulmonary sarcoidosis. JAMA 287:1301–1307CrossRefPubMedGoogle Scholar
  17. 17.
    Stern, et al. (1985) Sarcoidosis and its neurological manifestations. Arch Neurol 42:909–917PubMedGoogle Scholar
  18. 18.
    Stern, et al. (1987) Neurosarcoidosis: cerebrospinal fluid lymphocyte subpopulations. Neurology 37:878–881PubMedGoogle Scholar
  19. 19.
    Sulavik SB, et al. (1990) Recognition of distinctive patterns of gallium–67 distribution in sarcoidosis. J Nucl Med 31:1909–1914PubMedGoogle Scholar
  20. 20.
    Takada K, et al. (1993) The clinical course and prognosis of patients with severe, moderate or mild sarcoidosis. J Clin Epidemiol 46:359–366CrossRefPubMedGoogle Scholar
  21. 21.
    Vrethem, et al. (1998) CD4 and CD8 lymphocyte subsets in cerebrospinal fluid and peripheral blood from patients with multiple sclerosis, meningitis and normal controls. Acta Neurol Scand 97:215–220PubMedCrossRefGoogle Scholar
  22. 22.
    Zajicek, et al. (1999) Central nervous system sarcoidosis – diagnosis and management. Q J Med 92:103–117Google Scholar

Copyright information

© Steinkopff-Verlag 2006

Authors and Affiliations

  1. 1.Clinica Neurologica IIOspedale S.AntonioPadovaItaly

Personalised recommendations